Synergy Pharmaceuticals Company

Synergy Pharmaceuticals is a biopharmaceutical company developing novel therapies for the treatment of gastrointestinal conditions.

Total Funding: 407231243.0
Headquarters: New York, New York, United States
Funding Status: IPO
Employee Number: 101-250
Estimated Revenue: $10M to $50M
Last Funding Type: Post-IPO Debt
Technology: Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Last Funding Date: 2017-09-05
Investors Number: 1.0
Founded Date: 1992-02-11
Industry: Early Drug Development